ConductScience.org, home

Trial · NCT01799616

Efficiency and Safety Study of Pamidronate in Inflammatory Back Pain Due to Degenerative Disk Disease

NCT01799616, Phase 2, Unknown, University Hospital, Clermont-Ferrand

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Efficiency and Safety Study of Pamidronate in Inflammatory Back Pain Due to Degenerative Disk Disease. Trials, record NCT01799616. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01799616

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Efficiency and Safety Study of Pamidronate in Inflammatory Back Pain Due to Degenerative Disk Disease
NCT number
NCT01799616
Status
Unknown
Phases
Phase 2
Enrollment
48 participants, estimated
Lead sponsor
University Hospital, Clermont-Ferrand
Conditions
Intervertebral Disc Degeneration, Modic I Discopathy, Back Pain, Low Back Pain, Magnetic Resonance Imaging (MRI)
Interventions
Pamidronate, Placebo
First posted
2013-02-27
Last updated
2013-02-27

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primaryback pain assessed on a100mm VASat 3 months
Secondary- Functional status using EIFEL, Dallas, FABQ, MacTar, and MCII/PASS questionnairesat 6 weeks, 3 months, and 6 months
SecondaryBack stiffness assessed by Schober's test and finger-to-floor distanceat 6 weeks, 3 months, and 6 months
SecondaryInflammatory pain patternat 6 weeks, 3 months, and 6 monthsInflammatory pain pattern: number of nightly awakenings, as well as duration and intensity of morning stiffness on a 100mm VAS
Secondaryassess the efficacy of a rigid back brace in treating back painat 6 weeks, 3 months, and 6 monthsIn case of failure to reduce the pain with pamidronate at 3 months: assess the efficacy of a rigid back brace in treating back pain
SecondaryTolerance based on the number and types of side-effectsat 6 weeks, 3 months, and 6 months

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers1

The papers the trial lists on ClinicalTrials.gov.

PMIDListed as
24716739DERIVED

Source PubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT01799616

GET https://conductscience.org/api/trials/v1/NCT01799616/registered